| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000017345 |
| Receipt No. | R000020128 |
| Official scientific title of the study | Search of related factors with the hypoglycemia in use of the antibiotic containing pivoxyl group against infants |
| Date of disclosure of the study information | 2015/05/01 |
| Last modified on | 2017/03/14 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Search of related factors with the hypoglycemia in use of the antibiotic containing pivoxyl group against infants | |
| Title of the study (Brief title) | Antibiotic containing pivoxyl group and infants with hypoglycemia | |
| Region |
|
|
| Condition | |||
| Condition | Hypoglycemia | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The antibiotic containing pivoxyl group may cause hypoglycemia with hyper carnitinemia in long use of it. It is need for monitoring of it at the age from 0 to 5 years-old. This study investigates the transition of the urine and serum concentration of carnine and acyl-carnibitine and search of the useful factor for early prediction of hypoglycemia in use of antibiotic containing pivoxyl group. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The urine and serum concentration of carnitine and acyl-carnitine, plasma glucose level, biochemical laboratory data. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The infant patient taking the antibiotic containing pivoxyl group | |||
| Key exclusion criteria | No | |||
| Target sample size | ||||
| Research contact person | |
| Name of lead principal investigator | Nariyasu Mano |
| Organization | Tohoku university hospital |
| Division name | Department of pharmaceutical sciences |
| Address | 1-1 Seiryo-machi, Aoba-ku, Sendai |
| TEL | 022-717-7525 |
| mano@hosp.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Masamitsu Maekawa |
| Organization | Tohoku university hospital |
| Division name | Department of pharmaceutical sciences |
| Address | 1-1 Seiryo-machi, Aoba-ku, Sendai |
| TEL | 022-717-7541 |
| Homepage URL | |
| m-maekawa@hosp.tohoku.ac.jp | |
| Sponsor | |
| Institute | Department of pharmaceutical sciences, Tohoku university hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Grant-in-Aid |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | Division of pediatrics, Tohoku university hospital |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東北大学病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | However a simultaneous analytical method for carnnitine metabolites and the antibiotic drug was developed, no samples from patients with adverse effects by antibiotics having pivoxyl group were recruited. |
| Other related information | The blood and urine concentration of carnitine and acyl-carnitine of patient with taking the antibiotic containing pivoxyl group are analyzed by LC/MS/MS and the factors related with adverse effect are searched. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020128 |